{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:16:23Z","timestamp":1791983783514,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003451","name":"Universidad del Pa\u00eds Vasco","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-026-01707-9","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:15:53Z","timestamp":1772601353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex-Dependent Dynamics of Behavioural and Neuropathological Changes in an A53T Alpha-Synuclein Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7488-1398","authenticated-orcid":false,"given":"Maider","family":"Zubelzu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8190-1461","authenticated-orcid":false,"given":"Raphaelle","family":"Bidgood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-6943","authenticated-orcid":false,"given":"Ane","family":"Murueta-Goyena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-4378","authenticated-orcid":false,"given":"Jos\u00e9 \u00c1ngel","family":"Ruiz-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-0987","authenticated-orcid":false,"given":"Jos\u00e9 Vicente","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7601-4914","authenticated-orcid":false,"given":"Teresa","family":"Morera-Herreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"4","key":"1707_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510x(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20(4):415\u2013455. https:\/\/doi.org\/10.1016\/0022-510x(73)90175-5","journal-title":"J Neurol Sci"},{"issue":"1","key":"1707_CR2","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41598-024-51225-1","volume":"14","author":"R Bidgood","year":"2024","unstructured":"Bidgood R, Zubelzu M, Ruiz-Ortega JA, Morera-Herreras T (2024) Automated procedure to detect subtle motor alterations in the balance beam test in a mouse model of early Parkinson\u2019s disease. Sci Rep 14(1):862. https:\/\/doi.org\/10.1038\/s41598-024-51225-1","journal-title":"Sci Rep"},{"issue":"2","key":"1707_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","volume":"23","author":"J Blesa","year":"2022","unstructured":"Blesa J, Foffani G, Dehay B, Bezard E, Obeso JA (2022) Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? Nat Rev Neurosci 23(2):115\u2013128. https:\/\/doi.org\/10.1038\/s41583-021-00542-9","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"1707_CR4","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/genes16091004","volume":"16","author":"E Bunnell","year":"2025","unstructured":"Bunnell E, Saltonstall E, Pederson A, Baxter C, Ramicciotti E, Robinson N, Sandholm P, O Niel A, Raber J (2025) Extinction of contextual fear memory and passive avoidance memory and subsequent anxiety-like and depressive-like behavior of A53T and A53T-L444P mice. Genes 16(9):1004. https:\/\/doi.org\/10.3390\/genes16091004","journal-title":"Genes"},{"key":"1707_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O\u2019Malley K (2013) Axon degeneration in Parkinson\u2019s disease. Exp Neurol 246:72\u201383. https:\/\/doi.org\/10.1016\/j.expneurol.2012.01.011","journal-title":"Exp Neurol"},{"key":"1707_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.nicl.2017.03.011","volume":"14","author":"SP Caminiti","year":"2017","unstructured":"Caminiti SP, Presotto L, Baroncini D, Garibotto V, Moresco RM, Gianolli L, Volont\u00e9 MA, Antonini A, Perani D (2017) Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson\u2019s disease. Neuroimage Clin 14:734\u2013740. https:\/\/doi.org\/10.1016\/j.nicl.2017.03.011","journal-title":"Neuroimage Clin"},{"issue":"2","key":"1707_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/neup.12812","volume":"42","author":"CJ Choong","year":"2022","unstructured":"Choong CJ, Mochizuki H (2022) Neuropathology of \u03b1-synuclein in Parkinson\u2019s disease. Neuropathology 42(2):93\u2013103. https:\/\/doi.org\/10.1111\/neup.12812","journal-title":"Neuropathology"},{"issue":"8","key":"1707_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1586\/14737175.2014.936388","volume":"14","author":"S Coakeley","year":"2014","unstructured":"Coakeley S, Martens KE, Almeida QJ (2014) Management of anxiety and motor symptoms in Parkinson\u2019s disease. Expert Rev Neurother 14(8):937\u2013946. https:\/\/doi.org\/10.1586\/14737175.2014.936388","journal-title":"Expert Rev Neurother"},{"key":"1707_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnagi.2020.00118","volume":"12","author":"G Costa","year":"2020","unstructured":"Costa G, Sisalli MJ, Simola N, Della Notte S, Casu MA, Serra M, Pinna A, Feliciello A, Annunziato L, Scorziello A, Morelli M (2020) Gender differences in neurodegeneration, neuroinflammation and Na+-Ca2+\u2009exchangers in the female A53T Transgenic mouse model of Parkinson\u2019s disease. Front Aging Neurosci 12:118. https:\/\/doi.org\/10.3389\/fnagi.2020.00118","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"1707_CR10","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/cne.24468","volume":"526","author":"V Delic","year":"2018","unstructured":"Delic V, Chandra S, Abdelmotilib H, Maltbie T, Wang S, Kem D, Scott HJ, Underwood RN, Liu Z, Volpicelli-Daley LA, West AB (2018) Sensitivity and specificity of phospho-Ser129 \u03b1-synuclein monoclonal antibodies. J Comp Neurol 526(12):1978\u20131990. https:\/\/doi.org\/10.1002\/cne.24468","journal-title":"J Comp Neurol"},{"key":"1707_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neuro.2021.05.015","volume":"85","author":"I Deng","year":"2021","unstructured":"Deng I, Wiese MD, Zhou XF, Bobrovskaya L (2021) The efficacy of systemic administration of lipopolysaccharide in modelling pre-motor Parkinson\u2019s disease in C57BL\/6 mice. Neurotoxicology 85:254\u2013264. https:\/\/doi.org\/10.1016\/j.neuro.2021.05.015","journal-title":"Neurotoxicology"},{"issue":"Pt 5","key":"1707_CR12","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283\u20132301. https:\/\/doi.org\/10.1093\/brain\/114.5.2283","journal-title":"Brain"},{"issue":"3","key":"1707_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.ajpath.2012.11.018","volume":"182","author":"D Games","year":"2013","unstructured":"Games D, Seubert P, Rockenstein E, Patrick C, Trejo M, Ubhi K, Ettle B, Ghassemiam M, Barbour R, Schenk D, Nuber S, Masliah E (2013) Axonopathy in an \u03b1-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated \u03b1-synuclein. Am J Pathol 182(3):940\u2013953. https:\/\/doi.org\/10.1016\/j.ajpath.2012.11.018","journal-title":"Am J Pathol"},{"issue":"11","key":"1707_CR14","doi-asserted-by":"publisher","first-page":"e81426","DOI":"10.1371\/journal.pone.0081426","volume":"8","author":"SE Gombash","year":"2013","unstructured":"Gombash SE, Manfredsson FP, Kemp CJ, Kuhn NC, Fleming SM, Egan AE, Grant LM, Ciucci MR, MacKeigan JP, Sortwell CE (2013) Morphological and behavioral impact of AAV2\/\u00ad5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PLoS ONE 8(11):e81426. https:\/\/doi.org\/10.1371\/journal.pone.0081426","journal-title":"PLoS ONE"},{"issue":"7","key":"1707_CR15","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/s41593-024-01649-9","volume":"27","author":"NL Goodwin","year":"2024","unstructured":"Goodwin NL, Choong JJ, Hwang S et al (2024) Simple Behavioral Analysis (SimBA) as a platform for explainable machine learning in behavioral neuroscience. Nat Neurosci 27(7):1411\u20131424. https:\/\/doi.org\/10.1038\/s41593-024-01649-9","journal-title":"Nat Neurosci"},{"key":"1707_CR16","doi-asserted-by":"publisher","first-page":"115264","DOI":"10.1016\/j.expneurol.2025.115264","volume":"389","author":"JY Hong","year":"2025","unstructured":"Hong JY, Lee JS, Kim SH, Lee PH (2025) A model of l-dopa-induced dyskinesia in parkinsonian mice produced by aav vector-mediated overexpression of \u0391-Synuclein. Exp Neurol 389:115264. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115264","journal-title":"Exp Neurol"},{"issue":"1","key":"1707_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-017-0416-x","volume":"5","author":"CW Ip","year":"2017","unstructured":"Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, Volkmann J, Koprich JB (2017) AAV1\/2-induced overexpression of A53T-\u03b1-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson\u2019s disease. Acta Neuropathol Commun 5(1):11. https:\/\/doi.org\/10.1186\/s40478-017-0416-x","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1707_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0304-3940(99)00411-5","volume":"269","author":"R Jakes","year":"1999","unstructured":"Jakes R, Crowther RA, Lee VM, Trojanowski JQ, Iwatsubo T, Goedert M (1999) Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein. Neurosci Lett 269(1):13\u201316. https:\/\/doi.org\/10.1016\/s0304-3940(99)00411-5","journal-title":"Neurosci Lett"},{"issue":"3","key":"1707_CR19","doi-asserted-by":"publisher","first-page":"e28643","DOI":"10.1097\/MD.0000000000028643","volume":"101","author":"KW Kang","year":"2022","unstructured":"Kang KW, Choi SM, Kim BC (2022) Gender differences in motor and non-motor symptoms in early Parkinson disease. Medicine 101(3):e28643. https:\/\/doi.org\/10.1097\/MD.0000000000028643","journal-title":"Medicine"},{"key":"1707_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2018.02.047","volume":"51","author":"R Kim","year":"2018","unstructured":"Kim R, Lee J, Kim Y, Kim A, Jang M, Kim HJ, Jeon B, Kang UJ, Fahn S (2018) Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson\u2019s disease: An analysis of the PPMI cohort. Parkinsonism Relat Disord 51:49\u201354. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.047","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"1707_CR21","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease. Pathophysiologic and clinical implications. N Engl J Med 318(14):876\u2013880. https:\/\/doi.org\/10.1056\/NEJM198804073181402","journal-title":"N Engl J Med"},{"key":"1707_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1326-5-43","volume":"5","author":"JB Koprich","year":"2010","unstructured":"Koprich JB, Johnston TH, Reyes MG, Sun X, Brotchie JM (2010) Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1\/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson\u2019s disease. Mol Neurodegener 5:43. https:\/\/doi.org\/10.1186\/1750-1326-5-43","journal-title":"Mol Neurodegener"},{"issue":"9","key":"1707_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","volume":"18","author":"JB Koprich","year":"2017","unstructured":"Koprich JB, Kalia LV, Brotchie JM (2017) Animal models of \u03b1-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci 18(9):515\u2013529. https:\/\/doi.org\/10.1038\/nrn.2017.75","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"1707_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/biom13060977","volume":"13","author":"J Lamontagne-Proulx","year":"2023","unstructured":"Lamontagne-Proulx J, Coulombe K, Morissette M, Rieux M, Calon F, Di Paolo T, Soulet D (2023) Sex and age differences in a progressive synucleinopathy mouse model. Biomolecules 13(6):977. https:\/\/doi.org\/10.3390\/biom13060977","journal-title":"Biomolecules"},{"issue":"4","key":"1707_CR25","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/ejn.13493","volume":"45","author":"N Landeck","year":"2017","unstructured":"Landeck N, Buck K, Kirik D (2017) Toxic effects of human and rodent variants of alpha-synuclein in vivo. Eur J Neurosci 45(4):536\u2013547. https:\/\/doi.org\/10.1111\/ejn.13493","journal-title":"Eur J Neurosci"},{"issue":"3","key":"1707_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.14802\/jmd.15031","volume":"8","author":"JJ Lee","year":"2015","unstructured":"Lee JJ, Ham JH, Lee PH, Sohn YH (2015) Gender differences in age-related striatal dopamine depletion in Parkinson\u2019s disease. J Mov Disord 8(3):130\u2013135. https:\/\/doi.org\/10.14802\/jmd.15031","journal-title":"J Mov Disord"},{"issue":"5","key":"1707_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5607\/en25022","volume":"34","author":"Y Liang","year":"2025","unstructured":"Liang Y, Zhou L, Liu H, Huang X, Li Y, Li X, Huang S (2025) G protein-coupled estrogen receptor activation exerts protective effects via modulating brain and gut NLRP3 inflammasome in Parkinson\u2019s disease. Exp Neurobiol 34(5):200\u2013213. https:\/\/doi.org\/10.5607\/en25022","journal-title":"Exp Neurobiol"},{"issue":"7","key":"1707_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","volume":"18","author":"A Mirelman","year":"2019","unstructured":"Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, Hass CJ, Hausdorff JM, Pelosin E, Almeida QJ (2019) Gait impairments in Parkinson\u2019s disease. Lancet Neurol 18(7):697\u2013708. https:\/\/doi.org\/10.1016\/S1474-4422(19)30044-4","journal-title":"Lancet Neurol"},{"key":"1707_CR29","doi-asserted-by":"publisher","first-page":"113968","DOI":"10.1016\/j.bbr.2022.113968","volume":"432","author":"T Musacchio","year":"2022","unstructured":"Musacchio T, Yin J, Kremer F, Koprich JB, Brotchie JM, Volkmann J, Ip CW (2022) Temporal, spatial and molecular pattern of dopaminergic neurodegeneration in the AAV-A53T \u03b1-synuclein rat model of Parkinson\u2019s disease. Behav Brain Res 432:113968. https:\/\/doi.org\/10.1016\/j.bbr.2022.113968","journal-title":"Behav Brain Res"},{"issue":"7","key":"1707_CR30","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41596-019-0176-0","volume":"14","author":"T Nath","year":"2019","unstructured":"Nath T, Mathis A, Chen AC, Patel A, Bethge M, Mathis MW (2019) Using DeepLabCut for 3D markerless pose estimation across species and behaviors. Nat Protoc 14(7):2152\u20132176. https:\/\/doi.org\/10.1038\/s41596-019-0176-0","journal-title":"Nat Protoc"},{"issue":"2","key":"1707_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/brain\/aws358","volume":"136","author":"S Nuber","year":"2013","unstructured":"Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Sch\u00f6nig K, Zimmermann F, Bauer C, Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, M\u00fcller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J, Masliah E, Riess O (2013) A progressive dopaminergic phenotype associated with neurotoxic conversion of \u03b1-synuclein in BAC-transgenic rats. Brain 136(2):412\u2013432. https:\/\/doi.org\/10.1093\/brain\/aws358","journal-title":"Brain"},{"key":"1707_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-8-44","volume":"8","author":"M Oliveras-Salv\u00e1","year":"2013","unstructured":"Oliveras-Salv\u00e1 M, Van der Perren A, Casadei N, Stroobants S, Nuber S, D\u2019Hooge R, Van den Haute C, Baekelandt V (2013) rAAV2\/\u00ad7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Mol Neurodegener 8:44. https:\/\/doi.org\/10.1186\/1750-1326-8-44","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1707_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/jnnp.54.1.30","volume":"54","author":"B Pakkenberg","year":"1991","unstructured":"Pakkenberg B, M\u00f8ller A, Gundersen HJ, Mouritzen Dam A, Pakkenberg H (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson\u2019s disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 54(1):30\u201333. https:\/\/doi.org\/10.1136\/jnnp.54.1.30","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1707_CR34","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2004","unstructured":"Paxinos G, Franklin K (2004) The mouse brain in stereotaxic coordinates. Elsevier Science, Amsterdam"},{"issue":"1","key":"1707_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-06724-9","volume":"7","author":"JA Phan","year":"2017","unstructured":"Phan JA, Stokholm K, Zareba-Paslawska J, Jakobsen S, Vang K, Gjedde A, Landau AM, Romero-Ramos M (2017) Early synaptic dysfunction induced by \u03b1-synuclein in a rat model of Parkinson\u2019s disease. Sci Rep 7(1):1\u201317. https:\/\/doi.org\/10.1038\/s41598-017-06724-9","journal-title":"Sci Rep"},{"key":"1707_CR36","doi-asserted-by":"publisher","first-page":"109640","DOI":"10.1016\/j.jneumeth.2022.109640","volume":"378","author":"L Quintino","year":"2022","unstructured":"Quintino L, Gubinelli F, Sarauskyte L, Arvidsson E, Davidsson M, Lundberg C, Heuer A (2022) Automated quantification of neuronal swellings in a preclinical rodent model of Parkinson\u2019s disease detects region-specific changes in pathology. J Neurosci Methods 378:109640. https:\/\/doi.org\/10.1016\/j.jneumeth.2022.109640","journal-title":"J Neurosci Methods"},{"issue":"38","key":"1707_CR37","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1523\/JNEUROSCI.0313-19.2019","volume":"39","author":"MM Rajsombath","year":"2019","unstructured":"Rajsombath MM, Nam AY, Ericsson M, Nuber S (2019) Female sex and brain-selective estrogen benefit \u03b1-synuclein tetramerization and the PD-like motor syndrome in 3K transgenic mice. J Neurosci 39(38):7628\u20137640. https:\/\/doi.org\/10.1523\/JNEUROSCI.0313-19.2019","journal-title":"J Neurosci"},{"issue":"4","key":"1707_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.parkreldis.2013.01.008","volume":"19","author":"K Rugbjerg","year":"2013","unstructured":"Rugbjerg K, Christensen J, Tj\u00f8nneland A, Olsen JH (2013) Exposure to estrogen and women\u2019s risk for Parkinson\u2019s disease: a prospective cohort study in Denmark. Parkinsonism Relat Disord 19(4):457\u2013460. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.01.008","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1707_CR39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ana.410260409","volume":"26","author":"D Scherman","year":"1989","unstructured":"Scherman D, Desnos C, Darchen F, Pollak P, Javoy-Agid F, Agid Y (1989) Striatal dopamine deficiency in Parkinson\u2019s disease: role of aging. Ann Neurol 26(4):551\u2013557. https:\/\/doi.org\/10.1002\/ana.410260409","journal-title":"Ann Neurol"},{"issue":"2","key":"1707_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma M, Burr\u00e9 J (2023) \u03b1-Synuclein in synaptic function and dysfunction. Trends Neurosci 46(2):153\u2013166. https:\/\/doi.org\/10.1016\/j.tins.2022.11.007","journal-title":"Trends Neurosci"},{"issue":"7","key":"1707_CR41","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41419-018-0775-7","volume":"9","author":"R Sirabella","year":"2018","unstructured":"Sirabella R, Sisalli MJ, Costa G, Omura K, Ianniello G, Pinna A, Morelli M, Di Renzo GM, Annunziato L, Scorziello A (2018) NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson\u2019s Disease. Cell Death Dis 9(7):725. https:\/\/doi.org\/10.1038\/s41419-018-0775-7","journal-title":"Cell Death Dis"},{"issue":"1\u20132","key":"1707_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jns.2012.07.026","volume":"323","author":"P Solla","year":"2012","unstructured":"Solla P, Cannas A, Ibba FC, Loi F, Corona M, Orofino G, Marrosu MG, Marrosu F (2012) Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson\u2019s disease. J Neurol Sci 323(1\u20132):33\u201339. https:\/\/doi.org\/10.1016\/j.jns.2012.07.026","journal-title":"J Neurol Sci"},{"issue":"6","key":"1707_CR43","doi-asserted-by":"publisher","first-page":"e0131281","DOI":"10.1371\/journal.pone.0131281","volume":"10","author":"LK Song","year":"2015","unstructured":"Song LK, Ma KL, Yuan YH, Mu Z, Song XY, Niu F, Han N, Chen NH (2015) Targeted overexpression of \u0391-synuclein by rAAV2\/\u00ad1 vectors induces progressive nigrostriatal degeneration and increases vulnerability to MPTP in mouse. PLoS ONE 10(6):e0131281. https:\/\/doi.org\/10.1371\/journal.pone.0131281","journal-title":"PLoS ONE"},{"issue":"3","key":"1707_CR44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11481-020-09972-1","volume":"16","author":"N Thadathil","year":"2021","unstructured":"Thadathil N, Xiao J, Hori R, Alway SE, Khan MM (2021) Brain selective estrogen treatment protects dopaminergic neurons and preserves behavioral function in MPTP-induced mouse model of Parkinson\u2019s disease. J Neuroimmune Pharmacol 16(3):667\u2013678. https:\/\/doi.org\/10.1007\/s11481-020-09972-1","journal-title":"J Neuroimmune Pharmacol"},{"issue":"15","key":"1707_CR45","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","volume":"26","author":"GK Tofaris","year":"2006","unstructured":"Tofaris GK, Reitb\u00f6ck PG, Humby T, Lambourne SL, O\u2019Connell M, Ghetti B, Gossage H, Emson PC, Wilkinson LS, Goedert M, Spillantini MG (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human \u03b1-synuclein(1-120): implications for lewy body disorders. J Neurosci 26(15):3942\u20133950. https:\/\/doi.org\/10.1523\/JNEUROSCI.4965-05.2006","journal-title":"J Neurosci"},{"issue":"8","key":"1707_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna) 124(8):901\u2013905. https:\/\/doi.org\/10.1007\/s00702-017-1686-y","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"1707_CR47","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.neurobiolaging.2014.11.015","volume":"36","author":"A Van der Perren","year":"2015","unstructured":"Van der Perren A, Toelen J, Casteels C, Macchi F, Van Rompuy AS, Sarre S, Casadei N, Nuber S, Himmelreich U, Osorio Garcia MI, Michotte Y, D\u2019Hooge R, Bormans G, Van Laere K, Gijsbers R, Van den Haute C, Debyser Z, Baekelandt V (2015) Longitudinal follow-up and characterization of a robust rat model for Parkinson\u2019s disease based on overexpression of alpha-synuclein with adeno-associated viral vectors. Neurobiol Aging 36(3):1543\u20131558. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.11.015","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1707_CR48","doi-asserted-by":"publisher","first-page":"011509","DOI":"10.1063\/5.0035610","volume":"5","author":"CM Weber","year":"2021","unstructured":"Weber CM, Clyne AM (2021) Sex differences in the blood-brain barrier and neurodegenerative diseases. APL Bioeng 5(1):011509. https:\/\/doi.org\/10.1063\/5.0035610","journal-title":"APL Bioeng"},{"issue":"3","key":"1707_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41386-020-00915-1","volume":"46","author":"JE Zachry","year":"2021","unstructured":"Zachry JE, Nolan SO, Brady LJ, Kelly SJ, Siciliano CA, Calipari ES (2021) Sex differences in dopamine release regulation in the striatum. Neuropsychopharmacology 46(3):491\u2013499. https:\/\/doi.org\/10.1038\/s41386-020-00915-1","journal-title":"Neuropsychopharmacology"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01707-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:15:56Z","timestamp":1781637356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01707-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1707"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01707-9","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental and animal protocols of this study were reviewed and approved by the Local Ethical Committee for Animal Research of the University of the Basque Country (EHU, CEEA, protocols M20\/2019\/219, M20-2022-215 and M30\/2019\/220). All experiments were performed in accordance with the European Community Council Directive on \u201cThe Protection of Animals Used for Scientific Purposes\u201d (2010\/63\/EU) and with the Spanish law (RD 53\/2013) on the care and use of laboratory animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"70"}}